Get the Stockscreener App
6.91
1.00%
-0.07
Lifeward Ltd stock is traded at $6.91, with a volume of 2,202.
It is down -1.00% in the last 24 hours and up +5.02% over the past month.
Lifeward Ltd is a medical device company that designs, develops, and commercializes life-changing solutions spanning the continuum of care in physical rehabilitation and recovery, delivering functional and health benefits in clinical settings as well as in the home and community. Its product offerings include the ReWalk Personal Exoskeleton, ReStore Exo-Suit, MYOLYN FES Cycling, and AlterG Anti-Gravity Systems. The company operates in the United States, which generates the majority of its revenue, as well as in Europe, Germany, Asia Pacific, and the rest of the world.
See More
Previous Close:
$6.98
Open:
$7.01
24h Volume:
2,202
Relative Volume:
0.23
Market Cap:
$19.45M
Revenue:
$20.92M
Net Income/Loss:
$-25.87M
P/E Ratio:
-0.3511
EPS:
-19.6815
Net Cash Flow:
$-15.02M
1W Performance:
+1.62%
1M Performance:
+5.02%
6M Performance:
-15.36%
1Y Performance:
-46.18%
1-Day Range:
$6.83
$7.01
1-Week Range:
$6.20
$7.10
52-Week Range:
$4.14
$13.08
Lifeward Ltd Stock (LFWD) Company Profile
Name
Lifeward Ltd
Sector
Industry
Phone
15082511154
Address
2 CABOT ROAD, HUDSON
Compare LFWD vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LFWD
Lifeward Ltd
|
6.91 | 19.45M | 20.92M | -25.87M | -15.02M | -19.68 |
ABT
Abbott Laboratories
|
88.41 | 153.99B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
307.80 | 118.00B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
79.34 | 101.86B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
45.29 | 67.32B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
87.36 | 50.30B | 6.30B | 1.07B | 1.09B | 1.8406 |
Lifeward Ltd Stock (LFWD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-10-25 | Initiated | Laidlaw | Buy |
| Apr-03-17 | Downgrade | Barclays | Equal Weight → Underweight |
| Dec-16-16 | Initiated | Oppenheimer | Outperform |
| Jul-15-16 | Initiated | Piper Jaffray | Overweight |
| May-22-15 | Upgrade | Canaccord Genuity | Hold → Buy |
| May-08-15 | Reiterated | Barclays | Equal Weight |
| Oct-07-14 | Initiated | Barclays | Equal Weight |
View All
Lifeward Ltd Stock (LFWD) Latest News
Lifeward Ltd (LFWD) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Lifeward Ltd (LFWD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Lifeward Ltd (LFWD) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Lifeward Ltd (LFWD) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Lifeward Ltd (LFWD) Institutional Confidence - TradingKey
Lifeward Ltd. (LFWD) Q1 2026 Earnings: Deep EPS Miss Tempered by Resilient Stock PerformanceProfit Warning Alert - newsline.com
LFWD Q1 2026 Earnings: Significant EPS Miss Amidst Unreported RevenueROIC Trend Report - newsline.com
Lifeward Ltd. (LFWD) Hovers Near Support as Minimal Downside Move Signals CautionLarge Cap Trends - newsline.com
Lifeward Ltd. (LFWD) Holds Steady Near Support Amid Quiet Trading SessionSector Leader Stocks - newsline.com
LFWD Q1 2026 Earnings: Significant EPS Miss Weighs on StockEPS Consistency Score - newsline.com
LFWD Q1 2026 Earnings: Significant EPS Miss Amid Challenging QuarterGuidance vs Actual - newsline.com
LFWD Technical Analysis | Trend, Signals & Chart Patterns | LIFEWARD LTD (NASDAQ:LFWD) - ChartMill
LFWD News | LIFEWARD LTD (NASDAQ:LFWD) - ChartMill
LFWD Q1 2026 Earnings: EPS Misses Estimates by Wide Margin, Revenue Not DisclosedEPS Revision Trend - newsline.com
Lifeward Q1 2026 Earnings: Significant EPS Miss Reflects Continued InvestmentEarnings Cycle Report - The Legal Advocate
LFWD Q1 2026 Earnings: EPS Misses Estimates by Wide Margin as Company Faces ChallengesMid-Term Outlook - newsline.com
Why Is Lifeward Ltd. (LFWD) Stock Down Today? - Meyka
Lifeward Ltd. (LFWD) Edges Higher as Support Holds, Resistance in FocusParabolic SAR - The Legal Advocate
Lifeward Ltd. (LFWD) Gains Ground: Testing Key Resistance at $7.48Death Cross - newsline.com
H.C. Wainwright Maintains Lifeward(LFWD.US) With Buy Rating, Maintains Target Price $10 - Moomoo
Lifeward Ltd. (LFWD) Nears Key Support Amid Modest DeclineSupport Level Bounce - newsline.com
Lifeward Ltd. (LFWD) Surges Over 11% as Shares Test Key ResistanceVolatility Stop - The Legal Advocate
Lifeward (LFWD) Q4 2025 Earnings Transcript - AOL.com
Lifeward’s Earnings Call Balances Setbacks and Strategy - The Globe and Mail
Lifeward (Nasdaq: LFWD) posts wider Q1 loss, adds Oratech and new convertible debt - Stock Titan
Lifeward (LFWD) Chief Medical Officer receives 15,000-share RSU award - Stock Titan
Lifeward (LFWD) Chief Medical Officer discloses 2,083 ordinary shares - Stock Titan
Lifeward promotes Keith Rose to chief medical officer By Investing.com - Investing.com Nigeria
Lifeward Ltd. Appoints Keith D. Rose, M.D. as Chief Medical Officer – SEC 8-K Filing May 2026 - Minichart
Lifeward appoints Keith D. Rose, M.D. as chief medical officer By Investing.com - Investing.com Australia
Lifeward appoints Keith D. Rose, M.D. as chief medical officer - Investing.com
Lifeward Names Keith D. Rose as Chief Medical Officer - TipRanks
Lifeward (NASDAQ: LFWD) appoints Keith D. Rose, M.D. as new CMO - Stock Titan
Lifeward promotes Keith Rose to chief medical officer - Investing.com
Lifeward Appoints Dr. Keith D. Rose as Chief Medical - GlobeNewswire
Lifeward Ltd.16079622026 - SEC.gov
Lifeward (LFWD) price target decreased by 37.93% to 4.59 - MSN
How The Lifeward (LFWD) Story Is Shifting With New Price Targets And Valuation Assumptions - Yahoo Finance
Lifeward Ltd (LFWD) Q1 2026 Earnings Call Highlights: Navigating Challenges and Seizing Growth Opportunities - GuruFocus
Lifeward Earnings Call Balances Growth With Disruptions - The Globe and Mail
Number of shareholders of Lifeward Ltd. – BOATS:LFWD - TradingView
Lifeward Q1 earnings preview - MSN
Earnings Call Summary | Lifeward(LFWD.US) Q1 2026 Earnings Conference - 富途牛牛
Lifeward 1Q Loss/Shr $6.70 >LFWD - Moomoo
Lifeward Q1 2026 Loss Deepens: -$3.13/Share vs -$0.34 Expected - AlphaStreet
Lifeward Ltd (LFWD) Q1 2026 Earnings Miss: EPS -$6.70 vs -$1.26 - GuruFocus
Lifeward (LFWD) Q1 2026 Earnings Transcript - AOL.com
Lifeward expects 2026 revenue similar to 2025 following Oratech acquisition and $10M convertible note financing - MSN
Lifeward Ltd. Q1 2026 Earnings Call Summary - Yahoo Finance
Lifeward (LFWD) Reports Q1 Loss, Lags Revenue Estimates - sharewise.com
Lifeward Ltd Stock (LFWD) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):